“Experimental Alzheimer's drug shows promise”
A clinical trial is now underway to test a new drug that shows promise for slowing the relentless progression of memory loss and mental decline in Alzheimer's patients. The drug is called T-817MA and it's designed to protect nerve cells in the brain. Learn more
Press Release
Mount Sinai Health System to Roll Out Microsoft Dragon Copilot
Nov 05, 2025 View All Press Releases
Press Release
NIH Awards $10 Million for the New York Regional Diabetes Research Center
Oct 23, 2025 View All Press Releases